These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11115173)

  • 1. AIDS-related Kaposi sarcoma: the role of local therapy for a systemic disease.
    Dezube BJ
    Arch Dermatol; 2000 Dec; 136(12):1554-6. PubMed ID: 11115173
    [No Abstract]   [Full Text] [Related]  

  • 2. Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: results of phase 1 and 2 trials.
    Duvic M; Friedman-Kien AE; Looney DJ; Miles SA; Myskowski PL; Scadden DT; Von Roenn J; Galpin JE; Groopman J; Loewen G; Stevens V; Truglia JA; Yocum RC
    Arch Dermatol; 2000 Dec; 136(12):1461-9. PubMed ID: 11115156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of AIDS-related cutaneous Kaposi's sarcoma with topical alitretinoin (9-cis-retinoic acid) gel. Panretin Gel North American Study Group.
    Walmsley S; Northfelt DW; Melosky B; Conant M; Friedman-Kien AE; Wagner B
    J Acquir Immune Defic Syndr; 1999 Nov; 22(3):235-46. PubMed ID: 10770343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alitretinoin (Panretin) gel 0.1%.
    Rhoads J
    J Assoc Nurses AIDS Care; 2001; 12(5):86-91. PubMed ID: 11565242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [HIV plus hepatitis C or Kaposi sarcoma. Treatment options in coinfection].
    MMW Fortschr Med; 2000 Mar; 142 Suppl 1():58-9. PubMed ID: 10863315
    [No Abstract]   [Full Text] [Related]  

  • 6. Topical 0.1% alitretinoin gel for classic Kaposi sarcoma.
    Morganroth GS
    Arch Dermatol; 2002 Apr; 138(4):542-3. PubMed ID: 11939830
    [No Abstract]   [Full Text] [Related]  

  • 7. [Kaposi's sarcoma treated with topical alitretinoin].
    González de Arriba A; Pérez-Gala S; Goiriz-Valdés R; Ríos-Buceta L; García-Díez A
    Actas Dermosifiliogr; 2007; 98(1):50-3. PubMed ID: 17374335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase III vehicle-controlled, multi-centered study of topical alitretinoin gel 0.1% in cutaneous AIDS-related Kaposi's sarcoma.
    Bodsworth NJ; Bloch M; Bower M; Donnell D; Yocum R;
    Am J Clin Dermatol; 2001; 2(2):77-87. PubMed ID: 11705307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon therapy for Kaposi sarcoma associated with acquired immunodeficiency syndrome: still a valid treatment option?
    Rouanet I; Lechiche C; Doncesco R; Mauboussin JM; Sotto A
    AIDS Patient Care STDS; 2013 Oct; 27(10):537-8. PubMed ID: 24050760
    [No Abstract]   [Full Text] [Related]  

  • 10. 9-cis-retinoic acid capsules in the treatment of AIDS-related Kaposi sarcoma: results of a phase 2 multicenter clinical trial.
    Aboulafia DM; Norris D; Henry D; Grossman RJ; Thommes J; Bundow D; Yocum RC; Stevens V
    Arch Dermatol; 2003 Feb; 139(2):178-86. PubMed ID: 12588223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gel approved for KS.
    AIDS Patient Care STDS; 1999 May; 13(5):309. PubMed ID: 10356816
    [No Abstract]   [Full Text] [Related]  

  • 12. Abatement of cutaneous Kaposi's sarcoma associated with cidofovir treatment.
    Simonart T; Noel JC; De Clercq E; Snoeck R
    Clin Infect Dis; 1998 Dec; 27(6):1562. PubMed ID: 9868698
    [No Abstract]   [Full Text] [Related]  

  • 13. Resolution of Kaposi's sarcoma associated with undetectable level of human herpesvirus 8 DNA in a patient with AIDS after protease inhibitor therapy.
    Burdick AE; Carmichael C; Rady PL; Tyring SK; Badiavas E
    J Am Acad Dermatol; 1997 Oct; 37(4):648-9. PubMed ID: 9344209
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of AIDS-associated Kaposi's sarcoma with oral tretinoin.
    Bonhomme L; Fredj G; Ecstein E; Maurisson G; Farabos C; Misset JL; Jasmin C
    Am J Hosp Pharm; 1994 Oct; 51(19):2417-9. PubMed ID: 7847408
    [No Abstract]   [Full Text] [Related]  

  • 15. [AIDS-associated sarcoma Kaposi: features of clinical manifestations, dynamics on a background of antiretroviral therapy].
    Iurchenko AV; Martynchuk NA; Vikhtiuk NV
    Lik Sprava; 2011; (7-8):81-5. PubMed ID: 22768744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abatement of cutaneous Kaposi's sarcoma associated with cidofovir treatment.
    Hammoud Z; Parenti DM; Simon GL
    Clin Infect Dis; 1998 May; 26(5):1233. PubMed ID: 9597261
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of Kaposi's sarcoma and other manifestations of AIDS with human chorionic gonadotropin.
    Harris PJ
    Lancet; 1995 Jul; 346(8967):118-9. PubMed ID: 7603190
    [No Abstract]   [Full Text] [Related]  

  • 18. Failure of topical 0.1% alitretinoin gel for classic Kaposi sarcoma: first European experience.
    Rongioletti F; Zaccaria E; Viglizzo G
    Br J Dermatol; 2006 Oct; 155(4):856-7. PubMed ID: 16965450
    [No Abstract]   [Full Text] [Related]  

  • 19. HIV-related skin diseases.
    Geusau A; Tschachler E
    J R Coll Physicians Lond; 1997; 31(4):374-9. PubMed ID: 9263963
    [No Abstract]   [Full Text] [Related]  

  • 20. Cutaneous HIV-associated Kaposi sarcoma: a potential setting for management by clinical observation.
    Beatrous SV; Grisoli SB; Riahi RR; Cohen PR
    Dermatol Online J; 2017 Jun; 23(6):. PubMed ID: 28633734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.